Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the feasibility and safety of giving the
combination of oxaliplatin and gemcitabine followed by radiation therapy and to learn whether
or not this drug combined with radiation therapy works in treating women with Mullerian
tumors of the uterus.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital Sanofi